Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The reticuloendothelial system (RES) is a network of phagocytic cells, primarily macrophages and their precursors (monocytes), distributed throughout the body. These cells play a critical role in clearing particles, pathogens, and soluble substances from circulation and tissues, and in modulating immune responses. They are involved in various physiological processes, including iron recycling, antigen presentation, and cytokine production. Dysfunction of the RES is associated with various diseases, including anemia, cancers, and lysosomal storage disorders.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reticuloendothelial System Phagocytic Cell (RES Phagocyte).